Back to Trades
Degnan Chris
Chief Financial OfficerCIK 0001741968
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Degnan Chris, Chief Financial Officer, accounts for 2 disclosed filings worth $37.1K, all concentrated in UroGen Pharma Ltd. (URGN), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $37.1K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 3 | URGN UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | Award | $0 |
| Oct 9 | URGN UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | Sell | $37.1K |
2 filings